期刊文献+

心房颤动患者血栓形成与血浆组织因子和组织因子途径抑制物的关系 被引量:3

Relationship between Atrial Thrombosis and Plasma Tissue Factor and Tissue Factor Pathway Inhibitor in Patients with Atrial Fibrillation
下载PDF
导出
摘要 目的检测心房颤动(AF)患者血浆组织因子(TF)和组织因子途径抑制物(TFPI)抗原的变化,探讨组织因子凝血途径在心房血栓形成机制中的作用。方法选择心房颤动患者64例,采用酶联免疫吸附(ELISA)方法测定血浆TF和TFPI抗原水平,并与对照组进行比较。结果①与正常对照组比较,AF组血浆TF抗原水平显著增高[(1060.0±669.8)pg/mLvs(423.6±245.1)pg/mL,P=0.000],总TFPI和游离TFPI抗原水平降低[(38.2±8.9)ng/mLvs(70.1±24.0)ng/mL,P=0.000;(26.3±8.0)ng/mLvs(41.2±16.7)ng/mL,P=0.000]。②伴左房血栓心房颤动组与无左房血栓心房颤动组比较,伴左房血栓心房颤动组TF抗原水平显著增高[(1431.4±564.5)pg/mLvs(904.6±660.3)pg/mL,P=0.004],总TFPI和游离TFPI抗原水平降低[(33.1±9.6)ng/mLvs(40.0±7.8)ng/mL,P=0.01;(22.9±8.2)ng/mLvs(22.7±7.4)ng/mL,P=0.048]。结论心房颤动患者血浆组织因子途径改变表现为凝血活性增高和抗凝活性减低,组织因子凝血途径参与了心房颤动患者心房血栓形成机制。 Purpose To investigate the relationship between the tissue factor coagulation pathway and the mechanisms of atrial thrombosis in patients with atrial fibrillation (AF) by measuring the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) antigens. Methods Sixty-four patients with AF were enrolled,the plasma levels of TF and TFPI antigen were measured by ELISA method.The results of patients with atrial fibrillation were compared with the normal control's,and the comparison was also done between the patients with atrial thrombus and no-thrombus. Results The plasma levels of TF antigen in patients with atrial fibrillation were significantly higher than the normal control [(1 060.0±669.8) pg/mL vs (432.6±245.1) pg/mL,P=0.000];the plasma levels of total TFPI antigen were lo- wer than normal control [ (38.2±8.9)ng/mL vs (70.0±24.0)ng/mL,P=0.000].The plasma levels of TF antigen in patients with atrial thrombus were higher than the patients with no-thrombus [(1 431.4± 564.5)pg/mL vs (904.6±660.3) pg/mL,P=0.004],the plasma levels of total TFPI antigen with thrombus were lower than the patients with no-thrombus [(33.1±9.6) ng/mL vs (40.0±7.8) ng/mL,P= 0.01]. Conclusions The changes of tissue factor coagulation pathway were involving in the mechanisms of atrial thrombosis in patients with atrial fibrillation.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2005年第4期451-454,共4页 Fudan University Journal of Medical Sciences
基金 上海市科委科研计划资助(034119913)
  • 相关文献

参考文献12

  • 1Broze GJ Jr. Tissue factor pathway inhibitor[J]. Thromb Haemost,1995,74: 90
  • 2Lip GYH, Lowe GDO, Rumley A, et al. Increased markers of thrombogenesis in chronic atrial fibrillation: Effects of Warfarin treatment. Br Heart J, 1995,73: 527
  • 3Minamino T, Kitakaze M, Sanada S, et al. Increased expression of P-selection on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation. Circulation, 1998,98:1721
  • 4Roldan V, Marin F, Marco P, et al. Hypofibrinolysis in atrial fibrillation. Am Heart J, 1998,136: 956
  • 5李华,李婧,孙荣同.冠心病心房颤动患者纤溶系统的变化及其临床意义[J].中国心血管病研究,2004,2(4):248-249. 被引量:2
  • 6王华,杨杰孚,刘芳,谭爱国,胡云建,曾学寨,褚德发,包承鑫,刘德平,佟佳宾.心房颤动患者血栓前状态研究[J].中国循环杂志,2002,17(6):410-412. 被引量:10
  • 7Conway DSG, Pearce LA, Chin BSP, et al. Plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 patients with non-valvular atrial fibrillation. Circulation, 2002; 106:1962
  • 8Conway DSG, Pearce LA, Chin BSP, et al. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation ,2003,107:3141
  • 9Nakamura Y, Nakamura K, fukushima-Kusano K, et al. Tissure factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thrombosis reseach ,2003,111:137
  • 10Chung NAY,Belgore F, Li-Saw-Hee FL, et al. Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor? Stroke ,2002,22:2187

二级参考文献14

  • 1[1]Lip GY. The prothrombotics state in atrial fibrillation:new insight, more question, and clear answers needed[J]. Am Heart J, 2000,140 (3): 348 - 350
  • 2[3]Igarashi Y, Yamaura M, I to M, et al. Elevated serum lipoprotein(a)is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation. A transesophageal echocardiographic study [J]. Am Heart J,1998,136(6): 965 - 977
  • 3[4]Heppell RM, Berkin KE, McLenachan J M, et al. Hae mostatic and haemodynamic abnormalities associated with left atrial thrombosis in nonrheumatic atrial fibrillation[J]. Heart, 1997,77: 407 - 411
  • 4[5]Marin Ortuno F, Roldan Schilling V, Marco Vera P, et al. Improvement in fibrinolytic function following anticoagulant treatment in chronic rheumatic atrial fibrillation[J]. Rev Esp Cardion, 1999,52: 25 - 30
  • 5[6]Mitusch R,Siemens HJ,Garbe M, et al. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy [J]. Thromb Haemost, 1996,75: 219 - 223
  • 6Li-Saw-Hee FL,Blann AD,Lip GYH.Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy,and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.Stroke,2000,31∶828-833.
  • 7Lip GYH,Lowe GDO,Rumley A,et al.Increased markers of thrombogenesis in chronic atrial fibrillation:Effects of Warfarin treatment.Br Heart J,1995,73∶527-533.
  • 8Kahn SR,Solymoss S,Flegel KM.Nonvalvular atrial fibrillation:evidence for a prothrombotic state.Can Med Assoc J,1997,157∶673-681.
  • 9Li-Saw-Hee FL,Blann AD,Lip GY.A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.J Am Coll Cardiol,2000,35∶1926-1931.
  • 10Kamiyama N.Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation:Rabbit experimental model.Jpn Circ J,1998,62∶837-843.

共引文献10

同被引文献17

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部